Ok. Things are happening quickly now. Here are the first cities where our film is opening on May 2nd:
1. Los Angeles – Sundance (Sunset 5),and AMC Burbank
2. New York – AMC Empire
3. Seattle – Sundance
4. Houston – Sundance
5. Phoenix – AMC Arizona Center
6. Chicago – AMC TBD
7. Philadelphia – AMC Neshaminy
8. Boston – AMC TBD
9. Miami – AMC Aventura
10. DC – AMC TBD
11. Atlanta – AMC Barrett Common
Please, lets sell these out so we can platform our film to the rest of the country. In the meantime, if you don’t see your local theater here, there is an alternative. We are working with a company called Gathr. Their link is below. They can book a screening for your group (or just a group of friends) to see our film in a local theater in virtually any community in America. The minimum is 50 tickets. We want to be in 100 cities between now and May 2nd. So please reach out to Gathr right away. Here is their website. Very exciting days. We won’t get another chance to get our message out. Please join us. http://www.gathr.us/films
VANCOUVER!! This is your chance to see a special screening of the award-winning film Decoding Annie Parker and help end breast cancer! Please join us on October 29th. Buy your tickets here!
The TORONTO STAR reports :
Tak Mak, of Princess Margaret Cancer Centre in Toronto, and Dr. Dennis Slamon of UCLA have announced a new sharpshooter anti-cancer drug funded through grants and donations, without direct government money.
“If anyone ever doubted their cash donation to fight cancer — or their run, walk, or cycle for a cure — actually made a difference they should check with Tak Mak and Dennis Slamon.
Assigned the decidedly unglamourous moniker CFI-400945, the new medication zeroes in on a novel target within cancer cells. Unlike normal cells, these rogue cells rely on a special enzyme, called PLK4, to foster their out-of-control multiplication. By attacking that enzyme the researchers hope that cancer can be stopped in its tracks without harming normal cells. As an added benefit, cancer patients would be spared many of the devastating side effects of conventional chemotherapy.
Laboratory tests and experiments on special mice with human cancer tumours indicate this approach can inhibit the growth of breast and ovarian cancers as well as colorectal, lung, prostate and other malignancies.”
The United States Supreme Court issued its unanimous decision today — freeing the naturally occurring BRCA genes from Myriad’s patents. Quoting from Lyle Denniston on the SCOTUS BLOG:
Pronouncing what may seem like a patent truism, the Supreme Court ruled unanimously on Thursday that biotech researchers have to create something to get monopoly protection to study and apply the phenomenon. Because Myriad Genetics, Inc., “did not create anything,” the Court struck down its patent on isolating human genes from the bloodstream, unchanged from their natural form. Because Myriad did create a synthetic form of the genes, however, that could be eligible for a patent, the Court concluded.
The decision was a major blow to a company that believed it had a right to be the sole user and analyst of two human genes that show a high risk, for women found to have them in their blood, of breast and ovarian cancer. But the ruling will give medical and scientific researchers, and family doctors, greater opportunity to help women patients discover their potential vulnerability to those types of cancer.
Long before Myriad thought about trying to patent the gene, genius geneticist Dr. Mary Claire King discovered after years and years of research what many women around the world knew: something deadly was being passed down in their families. The amazing story of one of those women, Annie Parker of Toronto Canada, and the work of Dr. Mary Claire King, are brilliantly, warmly, compassionately, and even sometimes humorously told in the movie Decoding Annie Parker by Steven Bernstein. In a tribute to all women who fight this battle every day, the filmmakers granted BRCA Gene Awareness, Inc., this non-profit, the opportunity to show the film around the world until mid-October to raise awareness and money to save women and their families from the scourge of breast cancer.
Carolyn Rodney,
Carolyn Rodney Home
Sidney Powell,
Sidney Powell P.C.
Katherine S. Hall, MD, FACR
Director of Mammography
Southwest Diagnostic Imaging Center
Dallas, Texas
Sidney Powell has been lead counsel in more than 500 federal appeals resulting in more than 180 published decisions. She represents clients in complex federal appeals and consults in complex federal litigation in civil and selective criminal cases. Her representative cases traverse the following areas of substantive law: real estate, employment law, asbestos injuries (the $3 billion class action against Fiberboard), health care and medical malpractice, environmental issues, oil and gas, contract claims, patent, trademark, copyright, and other civil actions. She has also represented judges and lawyers on ethical issues and sanctions. For most of the last decade, she has represented one of the Merrill Lynch executives in the Enron “Nigerian Barge” litigation, in which she uncovered evidence that the Enron Task Force Prosecutors “plainly suppressed” exculpatory evidence that was favorable to the defense.
Ms. Powell is an elected member of the American Law Institute and a Fellow of the American Academy of Appellate Lawyers for which she served in 2001-2002 as President. She has long been a member of the Board of Governors of the Fifth Circuit Bar Association for which she also served as President and as Editor of the Fifth Circuit Reporter for 20 years.
A Phi Beta Kappa graduate of the University of North Carolina, where she also attended law school, Ms. Powell was the youngest Assistant United States Attorney in the country when she began with the United States Attorney’s Office in the Western District of Texas in 1978. She later chaired its Appellate Section. Thereafter, she began an Appellate Section for the Northern District of Texas. She also served as an Assistant United States Attorney for the Eastern District of Virginia, where she obtained the conviction of a local attorney for bankruptcy fraud.
Ms. Powell has written and taught extensively in the area of federal appellate practice, including for the Attorney General’s Advocacy Institute of the United States Department of Justice. Her most recent publication is the Chapter Evaluating an Appeal–Strategic Thinking Before and During The Appeal in the book Appellate Practice in Federal and State Courts (Law Journal Press, September 2011).
She is currently working on a book and a screenplay and practicing law while assisting three significant charities.
